Rhumbline Advisers Vaxart, Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Vaxart, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 5,264 shares of VXRT stock, worth $4,316. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,264
Previous 5,526
4.74%
Holding current value
$4,316
Previous $7,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VXRT
# of Institutions
108Shares Held
40.6MCall Options Held
96.7KPut Options Held
239K-
Sio Capital Management, LLC New York, NY14.8MShares$12.1 Million3.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.95MShares$8.16 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.99MShares$3.27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$1.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$1.45 Million0.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $104M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...